Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Richard H. Weisler, MD, PA
mi
from
Raleigh, NC
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Richard H. Weisler, MD, PA
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Tulsa Clinical Research
mi
from
Tulsa, OK
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Tulsa Clinical Research
mi
from
Tulsa, OK
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Abington Neurological Associates
mi
from
Willow Grove, PA
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Abington Neurological Associates
mi
from
Willow Grove, PA
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Rhode Island Mood & Memory Research Institute
mi
from
East Providence, RI
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Rhode Island Mood & Memory Research Institute
mi
from
East Providence, RI
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Neurology Clinic, PC
mi
from
Cordova, TN
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Neurology Clinic, PC
mi
from
Cordova, TN
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Senior Adults Specialty Research
mi
from
Austin, TX
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Senior Adults Specialty Research
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
University of Utah Center for Alzheimer's Care, Imaging and Research
mi
from
Salt Lake City, UT
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
University of Utah Center for Alzheimer's Care, Imaging and Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Instituto Neurologia Bs As
mi
from
Ciudad Autonoma de Bs As,
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Instituto Neurologia Bs As
mi
from
Ciudad Autonoma de Bs As,
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Banner Alzheimer'S Institute
mi
from
Phoenix, AZ
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Banner Alzheimer'S Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Neuropsychiatric Research Center for Orange County
mi
from
Orange, CA
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Neuropsychiatric Research Center for Orange County
mi
from
Orange, CA
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
mi
from
Denver, CO
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
mi
from
Denver, CO
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Neuropsychiatric Research Center of Southwest Florida
mi
from
Fort Myers, FL
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Neuropsychiatric Research Center of Southwest Florida
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Infinity Clinical Research, LLC
mi
from
Hollywood, FL
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Infinity Clinical Research, LLC
mi
from
Hollywood, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Collier Neurologic Specialists
mi
from
Naples, FL
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Collier Neurologic Specialists
mi
from
Naples, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Progressive Medical Research
mi
from
Port Orange, FL
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Progressive Medical Research
mi
from
Port Orange, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Indiana University
mi
from
Indianapolis, IN
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Northeastern Pennsylvania Memory
mi
from
Plains, PA
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Northeastern Pennsylvania Memory
mi
from
Plains, PA
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Territory Neurology & Research Institute
mi
from
Tucson, AZ
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Territory Neurology & Research Institute
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Alzheimer's Research Corporation
mi
from
Manchester, NJ
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Alzheimer's Research Corporation
mi
from
Manchester, NJ
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Bioclinica Research
mi
from
Orlando, FL
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Bioclinica Research
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Bioclinica The Villages
mi
from
The Villages, FL
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Bioclinica The Villages
mi
from
The Villages, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Western Michigan University Homer Stryker M.D. School of Medicine Center for Clinical Research
mi
from
Kalamazoo, MI
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Western Michigan University Homer Stryker M.D. School of Medicine Center for Clinical Research
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Millennium Psychiatric Associates, LLC
mi
from
Saint Louis, MO
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Millennium Psychiatric Associates, LLC
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Banner Alzheimer'S Institute
mi
from
Phoenix, AZ
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Banner Alzheimer'S Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Banner Sun Health Research Institute
mi
from
Sun City, AZ
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Banner Sun Health Research Institute
mi
from
Sun City, AZ
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
University of Arizona Health Sciences Center
mi
from
Tucson, AZ
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
University of Arizona Health Sciences Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Neurology Center of North Orange County
mi
from
Fullerton, CA
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Neurology Center of North Orange County
mi
from
Fullerton, CA
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
UCSD Comprehensive Alzheimer's Program
mi
from
La Jolla, CA
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
UCSD Comprehensive Alzheimer's Program
mi
from
La Jolla, CA
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Uc Irvine Medical Center
mi
from
Orange, CA
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Uc Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Geriatric and Adult Psychiatry, LCC
mi
from
Hamden, CT
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Geriatric and Adult Psychiatry, LCC
mi
from
Hamden, CT
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Yale University, Alzheimer's Disease Research Unit
mi
from
New Haven, CT
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Yale University, Alzheimer's Disease Research Unit
mi
from
New Haven, CT
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Research Center for Clinical Studies, Inc.
mi
from
Norwalk, CT
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Research Center for Clinical Studies, Inc.
mi
from
Norwalk, CT
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Infinity Clinical Research, LLC
mi
from
Hollywood, FL
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Infinity Clinical Research, LLC
mi
from
Hollywood, FL
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
University of Miami Miller School of Medicine
mi
from
Miami, FL
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Scientific Clinical Research
mi
from
North Miami, FL
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Scientific Clinical Research
mi
from
North Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Renstar Medical Research
mi
from
Ocala, FL
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Renstar Medical Research
mi
from
Ocala, FL
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Meridien Research
mi
from
Tampa, FL
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Meridien Research
mi
from
Tampa, FL
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Neuro Trials Research, Inc
mi
from
Atlanta, GA
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Neuro Trials Research, Inc
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
SIU School of Medicine
mi
from
Springfield, IL
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
SIU School of Medicine
mi
from
Springfield, IL
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Indiana Medical Research
mi
from
ELkhart, IN
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Indiana Medical Research
mi
from
ELkhart, IN
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Indiana University Health Partners, Adult Neurology Clinic
mi
from
Indianapolis, IN
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Indiana University Health Partners, Adult Neurology Clinic
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
University of Kansas/Clinical and Translational Science Unit
mi
from
Fairway, KA
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
University of Kansas/Clinical and Translational Science Unit
mi
from
Fairway, KA
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
University of Kentucky Sanders-Brown Center on Aging Clinic
mi
from
Lexington, KY
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
University of Kentucky Sanders-Brown Center on Aging Clinic
mi
from
Lexington, KY
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Acadia Hospital
mi
from
Bangor, ME
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Acadia Hospital
mi
from
Bangor, ME
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Boston University Alzheimer's Disease Center
mi
from
Boston, MA
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Boston University Alzheimer's Disease Center
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
University of Michigan Health System/ Michigan Clinical Research Unit
mi
from
Ann Arbor, MI
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
University of Michigan Health System/ Michigan Clinical Research Unit
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Michigan State University
mi
from
East Lansing, MI
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Michigan State University
mi
from
East Lansing, MI
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Bronson Neurobehvioral Health
mi
from
Paw Paw, MI
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Bronson Neurobehvioral Health
mi
from
Paw Paw, MI
Click here to add this to my saved trials